20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants

Clinical trial NCT04546425 · COMPLETED

Trial details

NCT number: NCT04546425
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2020-09-09
Primary completion: 2022-04-22
Enrollment: 1258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.